文献速递神经重症脑血管病外科

异氟烷挥发性镇静在低级别动脉瘤性蛛网膜下腔出血后神经重症监护患者中的应用

Volatile Sedation With Isoflurane in Neurocritical Care Patients After Poor-grade Aneurysmal Subarachnoid Hemorrhage.
PubMed 文献 · World Neurosurg · 2023-02-11

这项前瞻性观察研究纳入11例低级别(WFNS 4-5级)动脉瘤性蛛网膜下腔出血患者,在入院第3至5天将静脉镇静转换为异氟烷挥发性镇静,评估转换前后脑参数及心肺参数。结果显示平均颅内压、脑灌注压和脑组织氧分压无显著变化,大脑中动脉平均血流速度显著增加,去甲肾上腺素用量显著增加。作者认为异氟烷镇静不损害颅内压或脑氧合,但脑灌注压的显著下降可能限制其在血流动力学不稳定或高血管升压药需求时的使用。

要点

  • 低级别aSAH患者转换为异氟烷镇静后平均ICP、CPP和PBrO2无显著变化。
  • 异氟烷镇静后大脑中动脉平均血流速度显著增加,去甲肾上腺素用量显著增加。
  • 作者认为异氟烷镇静不损害ICP或脑氧合,但CPP显著下降可能限制其使用。

核心结论

  • 异氟烷镇静不损害低级别aSAH患者的颅内压或脑氧合,但脑灌注压的显著下降可能限制挥发性药物在血流动力学不稳定或高血管升压药需求时的使用。

研究设计与样本

  • 前瞻性观察性研究,纳入11例低级别(世界神经外科医师联盟4-5级)动脉瘤性蛛网膜下腔出血患者。
  • 入院第3至5天,使用Sedaconda麻醉保存装置(Sedana Medical,瑞典丹德吕德)将静脉镇静转换为异氟烷挥发性镇静。
  • 在镇静转换前后(-12至+12小时)评估颅内压、脑灌注压、脑组织氧分压、大脑中动脉平均血流速度、局部脑氧饱和度及心肺参数;并回顾性分析静脉和挥发性镇静期间的灌注CT资料以评估脑血流量变化。

主要发现

  • 转换为异氟烷镇静后,平均颅内压、脑灌注压和脑组织氧分压无显著变化。
  • 平均局部脑氧饱和度呈非显著性升高趋势,大脑中动脉平均血流速度在开始挥发性镇静后显著增加。
  • 异氟烷镇静导致去甲肾上腺素给药显著增加。
  • 尽管平均吸气压力增加,观察到平均动脉血二氧化碳分压显著增加。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Volatile sedation after aneurysmal subarachnoid hemorrhage (aSAH) promises several advantages, but there are still concerns regarding intracranial hypertension due to vasodilatory effects. We prospectively analyzed cerebral parameters during the switch from intravenous to volatile sedation with isoflurane in patients with poor-grade (World Federation of Neurosurgical Societies grade 4-5) aSAH. METHODS: Eleven patients were included in this prospective observational study. Between day 3 and 5 after admission, intravenous sedation was switched to isoflurane using the Sedaconda Anesthetic Conserving Device (Sedana Medical, Danderyd, Sweden). Intracranial pressure (ICP), cerebral perfusion pressure (CPP), brain tissue oxygenation (PBrO2), cerebral mean flow velocities (MFVs; transcranial Doppler ultrasound) and regional cerebral oxygen saturation (rSO2, near-infrared spectroscopy monitoring), as well as cardiopulmonary parameters were assessed before and after the sedation switch (-12 to +12 hours). Additionally, perfusion computed tomography data during intravenous and volatile sedation were analyzed retrospectively for changes in cerebral blood flow. RESULTS: There were no significant changes in mean ICP, CPP, and PBrO2 after the sedation switch to isoflurane. Mean rSO2 showed a non-significant trend towards higher values, and mean MFV in the middle cerebral arteries increased significantly after the initiation of volatile sedation. Isoflurane sedation resulted in a significantly increased norepinephrine administration. Despite an increase in mean inspiratory pressure, we observed a significant increase in mean partial arterial pressure of carbon dioxide. CONCLUSIONS: Isoflurane sedation does not compromise ICP or cerebral oxygenation in poor-grade aSAH patients, but the significant depression of CPP could limit the use of volatiles in case of hemodynamic instability or high vasopressor demand.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ditz C, Baars H, Schacht H, et al. Volatile Sedation With Isoflurane in Neurocritical Care Patients After Poor-grade Aneurysmal Subarachnoid Hemorrhage. World Neurosurg. 2023. PMID: 36780983. doi:10.1016/j.wneu.2023.02.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。